Ali, O. (2013). Genetics of type 2 diabetes. World Journal of Diabetes, 4(4), 114.

 

Al-Goblan, A. S., Al-Alfi, M. A., & Khan, M. Z. (2014). Mechanism linking diabetes

mellitus and obesity. Diabetes, Metabolic Syndrome and Obesity: Targets and

Therapy, 7, 587.

 

Abd-Elbaky, A. E., Abo-El Matty, D. M., Mesbah, N. M., Saleh, S. M., & Hamid, A.

M. A. (2016). Adiponectin (+ 276 G/T), Tumor Necrosis Factor-alpha (-308 G/A)

and Interleukin-6 (-174 C/G) Genes Polymorphisms in Egyptian Type 2 Diabetic

Patients. Journal of Diabetes & Metabolism, 7(6).

 

Acharya, A. B., Thakur, S., Muddapur, M. V., & Kulkarni, R. D. (2016). Tumor

necrosis factor-α, interleukin-4 and-6 in the serum of health, chronic periodontitis,

and type 2 diabetes mellitus. Journal of Indian Society of Periodontology, 20(5),

509.

 

Akdis, M., Aab, A., Altunbulakli, C., Azkur, K., Costa, R. A., Crameri, R., & Frei, R.

(2016). Interleukins (from IL-1 to IL-38), interferons, transforming growth factor

β, and TNF-α: Receptors, functions, and roles in diseases. Journal of Allergy and

Clinical Immunology, 138(4), 984-1010.

 

AL-Janaby, M. S., AL-Ani, M. Q., & Rasheed, M. N. (2018). Relationship between

some immunological factors and type 2 diabetes mellitus in Iraqi patients. Asian

Journal of Pharmaceutical and Clinical Research, 11(6), 489-492.

 

Ali, N. S. M., Allela, O. Q., Salih, H. M., & Ahmed, I. H. (2018). Prevalence of Type

2 Diabetes Associated Complications in Kurd-istan Region Iraq. Journal of Basic

and Clinical Pharmacy, 9(2), 263.

 

Albrechtsen, A., Grarup, N., Li, Y., Sparsø, T., Tian, G., Cao, H., & Nie, C. (2013).

Exome sequencing-driven discovery of coding polymorphisms associated with

common metabolic phenotypes. Diabetologia, 56(2), 298-310.

 

Alsaid, A., El-Missiry, M., Hatata, E. S., Tarabay, M., & Settin, A. (2013). Association

of IL-4-590 C> T and IL-13-1112 C> T gene polymorphisms with the

susceptibility to Type 2 diabetes mellitus. Disease Markers, 35(4), 243-247.

 

Arababadi, M. K. (2010). Interleukin-4 gene polymorphisms in type 2 diabetic patients

with nephropathy. Iranian Journal of Kidney Diseases, 4(4), 302.

 

Ashif, C. M., Balasubramanian, T., & Pawan Kumar and Fasalu Rahiman, O. M.

(2017). Interleukin-6 (IL-6) gene polymorphisms associated with type 2 diabetes

mellitus in Kerala population. International Journal of Medical Research and

Pharmaceutical Sciences, 4 (1).

 

Assmann, T. S., de Almeida Brondani, L., Bauer, A. C., Canani, L. H., & Crispim, D.

(2014). Polymorphisms in the TLR3 gene are associated with risk for type 1 diabetes mellitus. 

European Journal of Endocrinology, 170(4), 519-527.

 

Animaw, W., & Seyoum, Y. (2017). Increasing prevalence of diabetes mellitus in a developing country 

and its related factors. Plos One, 12(11), e0187670.

 

Akash, M. S. H., Rehman, K., & Liaqat, A. (2018). Tumor necrosis factor-alpha: role in development 

of insulin resistance and pathogenesis of type 2 diabetes mellitus. Journal of Cellular 

Biochemistry, 119(1), 105-110.

 

Abbatecola, A. M., Ferrucci, L., Grella, R., Bandinelli, S., Bonafè, M., Barbieri, M., & Paolisso, 

G. (2004). Diverse effect of inflammatory markers on insulin resistance and insulin-resistance 

syndrome in the elderly. Journal of the American Geriatrics Society, 52(3), 399-404.

 

Ates, I. (2018). Type 2 diabetes mechanisms, role of cytokines and their variations in disease 

development. FABAD Journal of Pharmaceutical Sciences, 43(1), 31-40.

 

Acharya, A. B., Thakur, S., Muddapur, M. V., & Kulkarni, R. D. (2016). Tumor necrosis factor-α, 

interleukin-4 and-6 in the serum of health, chronic periodontitis, and type 2 diabetes mellitus. 

Journal of Indian Society of Periodontology, 20(5), 509.

 

Abrahamian, H., Endler, G., Exner, M., Mauler, H., Raith, M., Endler, L., & Irsigler,

K. (2007). Association of low-grade inflammation with nephropathy in type 2 diabetic patients: role 

of elevated CRP-levels and 2 different gene-polymorphisms of proinflammatory cytokines. 

Experimental and Clinical Endocrinology & Diabetes, 115(01), 38-41.

 

Arora, P., Garcia-Bailo, B., Dastani, Z., Brenner, D., Villegas, A., Malik, S., & Badawi,

A. (2011). Genetic polymorphisms of innate immunity-related inflammatory pathways and their 

association with factors related to type 2 diabetes. BMC Medical Genetics, 12(1), 95.

 

Banerjee, M., & Saxena, M. 2014. Genetic Polymorphisms of Cytokine Genes in Type 2 Diabetes 

Mellitus. World Journal of Diabetes, 5 5(4): 493.

 

Banerjee, M., & Saxena, M. (2012). Interleukin-1 (IL-1) family of cytokines: role in type 2 

diabetes. Clinica Chimica Acta, 413(15-16), 1163-1170.

 

Barry, J. C., Shakibakho, S., Durrer, C., Simtchouk, S., Jawanda, K. K., Cheung, S. T., & Little, 

J. P. (2016). Hyporesponsiveness to the anti-inflammatory action of interleukin-10 in type 2 

diabetes. Scientific Reports, 6, 21244.

 

Baynes, H. W. (2015). Classification, pathophysiology, diagnosis and management of diabetes 

mellitus. Journal of Diabetes Metabolism, 6(5), 1-9.

 

Boutens, L., & Stienstra, R. (2016). Adipose tissue macrophages: going off track during

obesity. Diabetologia, 59(5), 879-894.

 

Beltcheva, O., Boyadzhieva, M., Angelova, O., Mitev, V., Kaneva, R., & Atanasova, I.

(2014). The rs266729 single-nucleotide polymorphism in the adiponectin gene

shows association with gestational diabetes. Archives of Gynecology and

Obstetrics, 289(4), 743-748.

 

Boucher, J., Kleinridders, A., & Kahn, C. R. (2014). Insulin receptor signaling in

normal and insulin-resistant states. Cold Spring Harbor Perspectives in

Biology, 6(1), a009191.

 

Bennet, L., Johansson, S. E., Agardh, C. D., Groop, L., Sundquist, J., Råstam, L., &

Sundquist, K. (2011). High prevalence of type 2 diabetes in Iraqi and Swedish

residents in a deprived Swedish neighbourhood-a population based study. BMC

Public Health, 11(1), 303.

 

Bonnycastle, L. L., Chines, P. S., Hara, T., Huyghe, J. R., Swift, A. J., Heikinheimo,

P, & Narisu, N. (2013). Autosomal dominant diabetes arising from a Wolfram

syndrome 1 mutation. Diabetes Journal, 62(11), 3943-3950.

bt Khaza’ai, H. (2018). Review on Potential Vitamin D Mechanism with Type 2

Diabetes Mellitus Pathophysiology in Malaysia. Current Research in Nutrition

and Food Science Journal, 6(1), 01-11.

 

Bid, H., Konwar, R., Agrawal, C., & Banerjee, M. (2008). Association of IL-4 and IL-

1RN (receptor antagonist) gene variants and the risk of type 2 diabetes mellitus: a

study in the north Indian population. Indian Journal of Medical Sciences, 62(7),

259-266.

 

Bonnefond, A., & Froguel, P. (2015). Rare and common genetic events in type 2

diabetes: what should biologists know?. Cell Metabolism, 21(3), 357-368.

 

Bai, H., Jing, D., Guo, A., & Yin, S. (2014). Association between interleukin 10 gene

polymorphisms and risk of type 2 diabetes mellitus in a Chinese

population. Journal of International Medical Research, 42(3), 702-710.

 

Bouhaha, R., Baroudi, T., Ennafaa, H., Vaillant, E., Abid, H., Sassi, R., & Vaxillaire,

M. (2010). Study of TNFα-308G/A and IL6-174G/C polymorphisms in type 2

diabetes and obesity risk in the Tunisian population. Clinical Biochemistry, 43(6),

549-552.

 

Carpov, S., & Tortech, T. (2018). Secure top most significant genome variants search:

iDASH 2017 competition. BMC Medical Genomics, 11(4), 82.

 

Chang, H. W., Li, Y. H., Hsieh, C. H., Liu, P. Y., & Lin, G. M. (2016). Association of

body mass index with all-cause mortality in patients with diabetes: a systemic

review and meta-analysis. Cardiovascular Diagnosis and Therapy, 6(2), 109.

 

Chukwuani, U., Digban, K. A., Yovwin, G. D., & Chukwuebuni, N. J. (2016).

Prevalence of chronic complications of type 2 diabetes mellitus in a secondary

health centre in Niger Delta, Nigeria. International Journal of Research in

Medical Sciences, 4(4), 1080-1085.

 

Cieslak, Marek, Andrzej Wojtczak, and Michal Cieslak. 2015. Role of Pro-

Inflammatory Cytokines of Pancreatic Islets and Prospects of Elaboration of New

Methods for the Diabetes Treatment. Acta Biochimica Polonica 62(1): 15–21.

 

Chen, G., Bentley, A., Adeyemo, A., Shriner, D., Zhou, J., Doumatey, A., & Herbert,

A. (2012). Genome-wide association study identifies novel loci association with

fasting insulin and insulin resistance in African Americans. Human molecular

genetics, 21(20), 4530-4536.

 

Cho, Y. S., Chen, C. H., Hu, C., Long, J., Ong, R. T. H., Sim, X., & Chang, Y. C.

(2012). Meta-analysis of genome-wide association studies identifies eight new loci

for type 2 diabetes in east Asians. Nature Genetics, 44(1), 67.

 

Chang, Y. H., Huang, C. N., & Shiau, M. Y. (2004). The C-174G promoter

polymorphism of the interleukin-6 (IL-6) gene that affects insulin sensitivity in

Caucasians is not involved in the pathogenesis of Taiwanese type 2 diabetes

mellitus. European Cytokine Network, 15(2), 117-119.

 

De Bruijn, K. M. J., Arends, L. R., Hansen, B. E., Leeflang, S., Ruiter, R., & Van Eijck,

C. H. J. (2013). Systematic review and meta-analysis of the association between

diabetes mellitus and incidence and mortality in breast and colorectal

cancer. British Journal of Surgery, 100(11), 1421-1429.

 

Dorajoo, R., Liu, J., & Boehm, B. (2015). Genetics of type 2 diabetes and clinical

utility. Genes, 6(2), 372-384.

 

Dupuis, J., Langenberg, C., Prokopenko, I., Saxena, R., Soranzo, N., Jackson, A. U., &

Lindgren, C. M. (2010). New genetic loci implicated in fasting glucose

homeostasis and their impact on type 2 diabetes risk. Nature Genetics, 42(2), 105-

116.

 

Dragsbæk, K., Neergaard, J. S., Laursen, J. M., Hansen, H. B., Christiansen, C., Beck-

Nielsen, H., & Henriksen, K. 2016. Metabolic Syndrome and Subsequent Risk of

Type 2 Diabetes and Cardiovascular Disease in Elderly Women. Medicine, 95 36.

 

Einarson, T. R., Acs, A., Ludwig, C., & Panton, U. H. (2018). Prevalence of

cardiovascular disease in type 2 diabetes: a systematic literature review of

scientific evidence from across the world in 2007–2017. Cardiovascular

Diabetology, 17(1), 83.

 

Elbe-BuÈrger, A., Olt, S., Stingl, G., Egyed, A., Klubal, R., Mann, U., & Rot, A.

(2002). Overexpression of IL-4 alters the homeostasis in the skin. Journal of

Investigative Dermatology, 118(5), 767-778.

 

Erbagci, A. B., Tarakçioglu, M., Coskun, Y., Sivasli, E., & Namiduru, E. S. (2001).

Mediators of inflammation in children with type I diabetes mellitus: cytokines 

type I diabetic children. Clinical Biochemistry, 34(8), 645-650.

 

Elek, Z., Németh, N., Nagy, G., Németh, H., Somogyi, A., Hosszufalusi, N., & Rónai,

Z. (2015). Micro-RNA binding site polymorphisms in the WFS1 gene are risk

factors of diabetes mellitus. Plos One, 10(10), e0139519.

 

Erem, C., Kuzu, U. B., Deger, O., & Can, G. (2015). Prevalence of gestational diabetes

mellitus and associated risk factors in Turkish women: the Trabzon GDM

Study. Archives of Medical Science: AMS, 11(4), 724.

 

Festa, A., D’Agostino, R., Tracy, R. P., & Haffner, S. M. (2002). Elevated levels of

acute-phase proteins and plasminogen activator inhibitor-1 predict the

development of type 2 diabetes: the insulin resistance atherosclerosis

study. Diabetes, 51(4), 1131-1137.

 

Flannick, J., & Florez, J. C. (2016). Type 2 diabetes: genetic data sharing to advance

complex disease research. Nature Reviews Genetics, 17(9), 535.

 

Forbes, J. M., & Cooper, M. E. (2013). Mechanisms of diabetic

complications. Physiological Reviews, 93(1), 137-188.

 

Fernández-Real, J. M., Broch, M., Vendrell, J., Gutiérrez, C., Casamitjana, R., Pugeat,

M., ... & Ricart, W. (2000). Interleukin-6 gene polymorphism and insulin

sensitivity. Diabetes, 49(3), 517-520.

 

Galavi, H. R., Saravani, R., Alamdari, A. R., Ranjbar, N., Damani, E., & Khodakhier,

T. N. (2016). Evaluating the effect of the rs2229238 and the rs4845625 interleukin

6 receptor gene polymorphisms on body mass index and the risk of type 2 diabetes

in an iranian study population. International Journal of High Risk Behaviors and

Addiction, 5(4).

 

Gupta, D. L., Nagar, P. K., Kamal, V. K., Bhoi, S., & Rao, D. N. (2015). Clinical

relevance of single nucleotide polymorphisms within the 13 cytokine genes in

North Indian trauma hemorrhagic shock patients. Scandinavian Journal of

Trauma, Resuscitation and Emergency Medicine, 23(1), 96.

 

Gao, K., Ren, Y., Wang, J., Liu, Z., Li, J., Li, L., & Ohno, K. 2017. Interactions between

Genetic Polymorphisms of Glucose Metabolizing Genes and Smoking and

Alcohol Consumption in the Risk of Type 2 Diabetes Mellitus. Applied

Physiology, Nutrition, and Metabolism, 42: 1–24.

 

Geerlings, S. E., Brouwer, E. C., Van Kessel, K. C., Gaastra, W., Stolk, R. P., &

Hoepelman, A. I. (2000). Cytokine secretion is impaired in women with diabetes

mellitus. European Journal of Clinical Investigation, 30(11), 995-1001.

 

Grarup, N., Sandholt, C. H., Hansen, T., & Pedersen, O. (2014). Genetic susceptibility

to type 2 diabetes and obesity: from genome-wide association studies to rare

variants and beyond. Diabetologia, 57(8), 1528-1541.

 

Gulati, K., Guhathakurta, S., Joshi, J., Rai, N., & Ray, A. (2016). Cytokines and their

role in health and disease: a brief overview. MedCrave Online Journal of

Immunology, 4(2), 00121.

 

Go, M. J., Hwang, J. Y., Kim, Y. J., Oh, J. H., Kim, Y. J., Kwak, S. H., & Cho, M. C.

(2013). New susceptibility loci in MYL2, C12orf51 and OAS1 associated with 1-

h plasma glucose as predisposing risk factors for type 2 diabetes in the Korean

population. Journal of Human Genetics, 58(6), 362-365.

 

Gudmundsson, J., Sulem, P., Steinthorsdottir, V., Bergthorsson, J. T., Thorleifsson, G.,

Manolescu, A., & Sigurdsson, A. (2007). Two variants on chromosome 17 confer

prostate cancer risk, and the one in TCF2 protects against type 2 diabetes. Nature

Genetics, 39(8), 977-983.

 

Grant, S. F., Thorleifsson, G., Reynisdottir, I., Benediktsson, R., Manolescu, A., Sainz,

J., & Styrkarsdottir, U. (2006). Variant of transcription factor 7-like 2 (TCF7L2)

gene confers risk of type 2 diabetes. Nature Genetics, 38(3), 320-323.

 

Gupta, S., Maratha, A., Siednienko, J., Natarajan, A., Gajanayake, T., Hoashi, S., &

Miggin, S. (2017). Analysis of inflammatory cytokine and TLR expression levels

in Type 2 Diabetes with complications. Scientific Reports, 7(1), 7633.

 

Guzmán-Flores, J. M., Escalante, M., Sánchez-Corona, J., García-Zapién, A. G., Cruz-

Quevedo, E. G., Munoz-Valle, J. F., & Flores-Martínez, S. E. (2013). Association

analysis between–308G/A and–238G/A TNF-alpha gene promoter

polymorphisms and insulin resistance in Mexican women with gestational

diabetes mellitus. Journal of Investigative Medicine, 61(2), 265-269.

 

Groop, L. C., Saloranta, C., Shank, M., Bonadonna, R. C., Ferrannini, E., & Defronzo,

R. A. (1991). The role of free fatty acid metabolism in the pathogenesis of insulin

resistance in obesity and noninsulin-dependent diabetes mellitus. The Journal of

Clinical Endocrinology and Metabolism, 72(1), 96-107.

 

Hartling, L., Dryden, D. M., Guthrie, A., Muise, M., Vandermeer, B., & Donovan, L.

(2013). Benefits and harms of treating gestational diabetes mellitus: a systematic

review and meta-analysis for the US Preventive Services Task Force and the

National Institutes of Health Office of Medical Applications of Research. Annals

of Internal Medicine, 159(2), 123-129.

 

Hashizume, M., and Mihara, M. (2011). IL-6 and lipid metabolism. Inflammation and

Regeneration, 31(3), 325-333.

 

Helaly, M. A. H., Hatata, E. S. Z., Abu-Elmagd, M., Ibrahem, E. F., Alsaid, A., El-Aal,

A. & Settin, A. (2013). Association of IL-10 and IL-6 Gene Polymorphisms with

Type 2 Diabetes Mellitus among Egyptian Patients. European Journal of General

Medicine, 10(3).

 

Ho, K. T., Shiau, M. Y., Chang, Y. H., Chen, C. M., Yang, S. C., & Huang, C. N.

(2010). Association of interleukin-4 promoter polymorphisms in Taiwanese

patients with type 2 diabetes mellitus. Metabolism, 59(12), 1717-1722.

 

Hu, C., & Jia, W. (2018). Diabetes in China: epidemiology and genetic risk factors and

their clinical utility in personalized medication. Diabetes, 67(1), 3-11.

Hu, Y., Bhupathiraju, S. N., Koning, L., & Hu, F. B. (2014). Duration of obesity and

overweight and risk of type 2 diabetes among US women. Obesity, 22(10), 2267-

2273.

 

Huang, Z. Q., Liao, Y. Q., Huang, R. Z., Chen, J. P., & Sun, H. L. (2018). Possible role

of TCF7L2 in the pathogenesis of type 2 diabetes mellitus. Biotechnology and

Biotechnological Equipment, 32(4), 830-834.

 

Hussain, M. K., Deli, F. A., Algenabi, A. H. A., & Abdul-Rudha, K. H. (2018).

Adiponectin gene polymorphisms as a predictor for development of type 2

diabetes mellitus in Iraqi population. Gene, 662, 118-122.

 

Huth, C., Illig, T., Herder, C., Gieger, C., Grallert, H., Vollmert, C., & Thorand, B.

(2009). Joint analysis of individual participants’ data from 17 studies on the

association of the IL6 variant-174G> C with circulating glucose levels,

interleukin-6 levels, and body mass index. Annals of Medicine, 41(2), 128-138.

 

Himelfarb, S. T., Silva, F. A., Arazi, S. S., Farjado, C. M., Garofalo, A., Bertolami, M.

C & Hirata, R. D. (2011). Tumor necrosis factor-α and interleukin-6 expression in

leukocytes and their association with polymorphisms and bone markers in diabetic

individuals treated with pioglitazone. Drug Metabolism and Drug

Interactions, 26(1), 37-40.

 

Herbert, A., Liu, C., Karamohamed, S., Schiller, J., Liu, J., Yang, Q., & Meigs, J. B.

(2005). The–174 IL-6 GG genotype is associated with a reduced risk of type 2

diabetes mellitus in a family sample from the National Heart, Lung and Blood

Institute’s Framingham Heart Study. Diabetologia, 48(8), 1492-1495.

 

Huth, C., Heid, I. M., Vollmert, C., Gieger, C., Grallert, H., Wolford, J. K., & Pedersen,

O. (2006). IL6 gene promoter polymorphisms and type 2 diabetes: joint analysis

of individual participants’ data from 21 studies. Diabetes, 55(10), 2915-2921.

 

Hotamisligil, G. S., Arner, P., Caro, J. F., Atkinson, R. L., & Spiegelman, B. M. (1995).

Increased adipose tissue expression of tumor necrosis factor-alpha in human

obesity and insulin resistance. The Journal of Clinical Investigation, 95(5), 2409-

2415.

 

Hotamisligil, G. S., Peraldi, P., Budavari, A., Ellis, R., White, M. F., & Spiegelman, B.

M. (1996). IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity

in TNF-α-and obesity-induced insulin resistance. Science, 271(5249), 665-670.

 

Illig, T., Bongardt, F., Schöpfer-Wendels, A., Huth, C., Heid, I., Rathmann, W., &

Wichmann, H. E. (2005). Genetics of type 2 diabetes: impact of interleukin-6 gene

variants. Das Gesundheitswesen, 67(S 01), 122-126.

 

Illig, T., Bongardt, F., Schopfer, A., Muller-Scholze, S., Rathmann, W., Koenig, W., &

Herder, C. (2004). Significant association of the interleukin-6 gene

polymorphisms C-174G and A-598G with type 2 diabetes. The Journal of Clinical

Endocrinology and Metabolism, 89(10), 5053-5058.

 

Jain, S. K., Kannan, K., Lim, G., Matthews-Greer, J., McVie, R., & Bocchini, J. A.

(2003). Elevated blood interleukin-6 levels in hyperketonemic type 1 diabetic

patients and secretion by acetoacetate-treated cultured U937 monocytes. Diabetes

Care, 26(7), 2139-2143.

 

Kwak, S. H., Choi, S. H., Kim, K., Jung, H. S., Cho, Y. M., Lim, S., & Jang, H. C.

(2013). Prediction of type 2 diabetes in women with a history of gestational

diabetes using a genetic risk score. Diabetologia, 56(12), 2556-2563.

 

Kahn, S. E., Cooper, M. E., & Del Prato, S. (2014). Pathophysiology and treatment of

type 2 diabetes: perspectives on the past, present, and future. The

Lancet, 383(9922), 1068-1083.

 

Kahn, S. E., Hull, R. L., & Utzschneider, K. M. (2006). Mechanisms linking obesity to

insulin resistance and type 2 diabetes. Nature, 444(7121), 840-846.

 

Kampan, N., Azman, H., Hafiz, I., Mohammad, H., Yee, C. S., & Abdul Ghani, N. A.

(2013). Outcome of pregnancy among Malaysian women with diabetes mellitus-–

a single centre experience. Malaysian Journal of Public Health Medicine, 13(2),

1-10.

 

Karamanou, Marianna. 2016. Milestones in the History of Diabetes Mellitus: The Main

Contributors. World Journal of Diabetes 7(1): 1.

 

Kaul, N., & Ali, S. (2016). Genes, genetics, and environment in type 2 diabetes:

implication in personalized medicine. DNA and Cell Biology, 35(1), 1-12.

 

Kautzky-Willer, A., Harreiter, J., & Pacini, G. (2016). Sex and gender differences in

risk, pathophysiology and complications of type 2 diabetes mellitus. Endocrine

Reviews, 37(3), 278-316.

 

Keith, R. J., Al Rifai, M., Carruba, C., De Jarnett, N., McEvoy, J. W., Bhatnagar, A.,

... & Defilippis, A. P. (2016). Tobacco use, insulin resistance, and risk of type 2

diabetes: results from the multi-ethnic study of atherosclerosis. PLoS One, 11(6),

e0157592.

 

Kiani, A., Garcia-Cózar, F. J., Habermann, I., Laforsch, S., Aebischer, T., Ehninger,

G., & Rao, A. (2001). Regulation of interferon-γ gene expression by nuclear factor

of activated T cells. Blood, 98(5), 1480-1488.

 

Kim, A. Y., Park, Y. J., Pan, X., Shin, K. C., Kwak, S. H., Bassas, A. F., & Kim, J. B.

(2015). Obesity-induced DNA hypermethylation of the adiponectin gene mediates

insulin resistance. Nature Communications, 6, 7585.

 

Kolb, H., & Martin, S. (2017). Environmental/lifestyle factors in the pathogenesis and

prevention of type 2 diabetes. BioMed Central Medicine, 15(1), 131.

 

Kommoju, U. J., Samy, S. K., Maruda, J., Irgam, K., Kotla, J. P., Velaga, L., & Reddy,

B. M. (2016). Association of CDKAL1, CDKN2A/B & HHEX gene

polymorphisms with type 2 diabetes mellitus in the population of Hyderabad,

India. The Indian Journal of Medical Research, 143(4), 455.

 

Kong, Y., Sharma, R. B., Nwosu, B. U., & Alonso, L. C. (2016). Islet biology, the

CDKN2A/B locus and type 2 diabetes risk. Diabetologia, 59(8), 1579-1593.

 

Kristiansen, O. P., & Mandrup-Poulsen, T. (2005). Interleukin-6 and diabetes: the good,

the bad, or the indifferent?. Diabetes, 54(suppl 2), S114-S124.

 

Kleiner, S., Gomez, D., Megra, B., Na, E., Bhavsar, R., Cavino, K., & Carrat, G. (2018).

Mice harboring the human SLC30A8 R138X loss-of-function mutation have

increased insulin secretory capacity. Proceedings of the National Academy of

Sciences, 115(32), E7642-E7649.

 

Kubaszek, A., Pihlajamäki, J., Punnonen, K., Karhapää, P., Vauhkonen, I., & Laakso,

M. (2003). The C-174G promoter polymorphism of the IL-6 gene affects energy

expenditure and insulin sensitivity. Diabetes, 52(2), 558-561.

 

Kabesch, M., Tzotcheva, I., Carr, D., Höfler, C., Weiland, S. K., Fritzsch, C., &

Martinez, F. D. (2003). A complete screening of the IL4 gene: novel

polymorphisms and their association with asthma and IgE in childhood. Journal

of Allergy and Clinical Immunology, 112(5), 893-898.

 

Kwak, S. H., & Park, K. S. (2016). Recent progress in genetic and epigenetic research

on type 2 diabetes. Experimental and Molecular Medicine, 48(3), e220.

 

Kooner, J. S., Saleheen, D., Sim, X., Sehmi, J., Zhang, W., Frossard, P., & Jafar, T.

(2011). Genome-wide association study in individuals of South Asian ancestry

identifies six new type 2 diabetes susceptibility loci. Nature Genetics, 43(10), 984-

989.

 

Kong, A., Steinthorsdottir, V., Masson, G., Thorleifsson, G., Sulem, P., Besenbacher,

S., & Frigge, M. L. (2009). Parental origin of sequence variants associated with

complex diseases. Nature, 462(7275), 868-874.

 

Kilpeläinen, T. O., Laaksonen, D. E., Lakka, T. A., Herder, C., Koenig, W., Lindström,

J., & Tuomilehto, J. (2010). The rs1800629 polymorphism in the TNF gene

interacts with physical activity on the changes in C-reactive protein levels in the

Finnish Diabetes Prevention Study. Experimental and Clinical Endocrinology and

Diabetes, 118(10), 757-759.

 

Kulseng, B., Skjåk-Braek, G., Følling, I., & Espevik, T. (1996). TNF production from

peripheral blood mononuclear cells in diabetic patients after stimulation with

alginate and lipopolysaccharide. Scandinavian Journal of Immunology, 43(3),

335-340.

 

Kubaszek, A., Pihlajamäki, J., Punnonen, K., Karhapää, P., Vauhkonen, I., & Laakso,

M. (2003). The C-174G promoter polymorphism of the IL-6 gene affects energy

expenditure and insulin sensitivity. Diabetes, 52(2), 558-561.

 

Kieffer, T. J., Heller, R. S., Leech, C. A., Holz, G. G., & Habener, J. F. (1997). Leptin

suppression of insulin secretion by the activation of ATP-sensitive K+ channels in

pancreatic β-cells. Diabetes, 46(6), 1087-1093.

 

Lakhtakia, R. 2013. The History of Diabetes Mellitus. Sultan Qaboos University

Medical Journal, 13 15(4): 336–42.

 

Lazic, M., Inzaugarat, M. E., Povero, D., Zhao, I. C., Chen, M., Nalbandian, M., &

Sears, D. D. (2014). Reduced dietary omega-6 to omega-3 fatty acid ratio and

12/15-lipoxygenase deficiency are protective against chronic high fat diet-induced

steatohepatitis. PloS One, 9(9), e107658.

 

Le, T. N., Elsea, S. H., Romero, R., Chaiworapongsa, T., & Francis, G. L. (2013).

Prolactin receptor gene polymorphisms are associated with gestational

diabetes. Genetic Testing and Molecular Biomarkers, 17(7), 567-571.

 

Liao, W. L., & Tsai, F. J. (2014). Personalized Medicine in Type 2 Diabetes. Bio

Medicine, 4 4(2): 1–8.

 

Lumeng, C. N., Bodzin, J. L., & Saltiel, A. R. (2007). Obesity induces a phenotypic

switch in adipose tissue macrophage polarization. The Journal of Clinical

Investigation, 117(1), 175-184.

 

Liese, Angela D., Xiaoguang Ma, David M. Maahs, and Jennifer L. Trilk. 2013.

Physical Activity, Sedentary Behaviors, Physical Fitness, and Their Relation to

Health Outcomes in Youth with Type 1 and Type 2 Diabetes: A Review of the

Epidemiologic Literature. Journal of Sport and Health Science, 2(1): 21–38.

 

Lim, S., Kim, M. J., Lim, S., Kim, M. J., Choi, S. H., Shin, C. S., & Choi, S. H. (2013).

Association of vitamin D deficiency with incidence of type 2 diabetes in high-risk

Asian subjects. The American Journal of Clinical Nutrition, 97(3), 524-530.

 

Lips, P., Eekhoff, M., van Schoor, N., Oosterwerff, M., de Jongh, R., Krul-Poel, Y., &

Simsek, S. (2017). Vitamin D and type 2 diabetes. The Journal of Steroid

Biochemistry and Molecular Biology, 173, 280-285.

 

Li, H., Gan, W., Lu, L., Dong, X., Han, X., Hu, C., & He, M. (2013). A genome-wide

association study identifies GRK5 and RASGRP1 as type 2 diabetes loci in

Chinese Hans. Diabetes, 62(1), 291-298.

 

Lumeng, C. N., Bodzin, J. L., & Saltiel, A. R. (2007). Obesity induces a phenotypic

switch in adipose tissue macrophage polarization. The Journal of Clinical

Investigation, 117(1), 175-184.

 

Little, S. (1995). Amplification-refractory mutation system (ARMS) analysis of point

mutations. Current Protocols in Human Genetics, 7(1), 9-8.

 

Logakodie, S., Azahadi, O., Fuziah, P., Norizzati, B. I. B., Tan, S. F., Zienna, Z. Z. R.,

& Sazidah, M. K. (2017). Gestational diabetes mellitus: The prevalence,

associated factors and foeto-maternal outcome of women attending antenatal

care. Malaysian family Physician: the Official journal of the Academy of Family

Physicians of Malaysia, 12(2), 9.

 

Luo, W., Guo, Z., Wu, M., Hao, C., Zhou, Z., & Yao, X. (2015). Interaction of smoking

and obesity on type 2 diabetes risk in a Chinese cohort. Physiology and

Behavior, 139, 240-243.

 

Lyssenko, V., & Laakso, M. (2013). Genetic screening for the risk of type 2 diabetes:

worthless or valuable?. Diabetes Care, 36(Supplement 2), S120-S126.

 

Libra, M., Signorelli, S. S., Bevelacqua, Y., Navolanic, P. M., Bevelacqua, V., Polesel,

J., & Malaponte, G. (2006). Analysis of G (-174) C IL-6 polymorphism and

plasma concentrations of inflammatory markers in patients with type 2 diabetes

and peripheral arterial disease. Journal of Clinical Pathology, 59(2), 211-215.

 

Maier, L. M., Chapman, J., Howson, J. M., Clayton, D. G., Pask, R., Strachan, D. P., &

Todd, J. A. (2005). No evidence of association or interaction between the IL4RA,

IL4, and IL13 genes in type 1 diabetes. The American Journal of Human

Genetics, 76(3), 517-521.

 

Malenica, M., Šilar, M., Dujic, T., Bego, T., Semiz, S., Škrbo, S., & Cauševic, A.

(2017). Importance of inflammatory markers and IL-6 for diagnosis and follow up

of patients with type 2 diabetes mellitus. Medicinski Glasnik, 14(2).

 

Mansour, A., & Al Douri, F. (2015). Diabetes in Iraq: facing the epidemic. A systematic

review. Wulfenia Journal, 22(3), 258-73.

 

Martinez, F. O., Sica, A., Mantovani, A., & Locati, M. (2008). Macrophage activation

and polarization. Front Bioscience, 13(1), 453-461.

 

Mohlke, K. L., & Boehnke, M. (2015). Recent advances in understanding the genetic

architecture of type 2 diabetes. Human Molecular Genetics, 24(R1), R85-R92.

 

Meybodi, H. R. A., Hasanzad, M., & Larijani, B. (2017). Path to personalized medicine

for type 2 diabetes mellitus: reality and hope. Acta Medica Iranica, 166-174.

 

Mendoza-Carrera, F., Ramírez-López, G., Ayala-Martínez, N. A., García-Zapién, A.

G., Flores-Martínez, S. E., & Sánchez-Corona, J. (2010). Influence of CRP, IL6,

and TNFA gene polymorphisms on circulating levels of C-reactive protein in

Mexican adolescents. Archives of Medical Research, 41(6), 472-477.

 

Manning, A. K., Hivert, M. F., Scott, R. A., Grimsby, J. L., Bouatia-Naji, N., Chen, H.,

... & Amin, N. (2012). A genome-wide approach accounting for body mass index

identifies genetic variants influencing fasting glycemic traits and insulin

resistance. Nature Genetics, 44(6), 659-669.

 

Martín-Timón, I., Sevillano-Collantes, C., Segura-Galindo, A., & del Cañizo-Gómez,

F. J. (2014). Type 2 diabetes and cardiovascular disease: have all risk factors the

same strength?. World Journal of Diabetes, 5(4), 444.

 

Morris, A. P., Voight, B. F., Teslovich, T. M., Ferreira, T., Segre, A. V.,

Steinthorsdottir, V., & Prokopenko, I. (2012). Large-scale association analysis

provides insights into the genetic architecture and pathophysiology of type 2

diabetes. Nature Genetics, 44(9), 981.

 

Mukhopadhyaya, P. N., Acharya, A., Chavan, Y., Purohit, S. S., & Mutha, A. (2010).

Metagenomic study of single-nucleotide polymorphism within candidate genes

associated with type 2 diabetes in an Indian population. Genetics and Molecular

Research, 9(4), 2060-8.

 

Mostafazadeh, A., Herder, C., Haastert, B., Hanifi-Moghaddam, P., Schloot, N.,

Koenig, W., & Kolb, H. (2005). Association of humoral immunity to human

Hsp60 with the IL-6 gene polymorphism C-174G in patients with type 2 diabetes

and controls. Hormone and Metabolic Research, 37(04), 257-263.

 

Mohlig, M., Boeing, H., Spranger, J., Osterhoff, M., Kroke, A., Fisher, E. V. A., &

Pfeiffer, A. F. (2004). Body mass index and C-174G interleukin-6 promoter

polymorphism interact in predicting type 2 diabetes. The Journal of Clinical

Endocrinology and Metabolism, 89(4), 1885-1890.

 

McNeely, M. J., Boyko, E. J., Weigle, D. S., Shofer, J. B., Chessler, S. D., Leonnetti,

D. L., & Fujimoto, W. Y. (1999). Association between baseline plasma leptin

levels and subsequent development of diabetes in Japanese Americans. Diabetes

Care, 22(1), 65-70.

 

Mahajan, A., Go, M. J., Zhang, W., Below, J. E., Gaulton, K. J., Ferreira, T., &

Saleheen, D. (2014). Genome-wide trans-ancestry meta-analysis provides insight

into the genetic architecture of type 2 diabetes susceptibility. Nature

genetics, 46(3), 234-244.

 

Nakatochi, M., Ichihara, S., Yamamoto, K., Ohnaka, K., Kato, Y., Yokota, S., &

Matsubara, T. (2015). Epigenome-wide association study suggests that SNPs in

the promoter region of RETN influence plasma resistin level via effects on DNA

methylation at neighbouring sites. Diabetologia, 58(12), 2781-2790.

 

Nazamuddin, M., Wadud, A., Ansari, A. H., Alam, T., Perveen, A., & Iqbal, N. (2014).

Concept of diabetes in Unani system of medicine: an overview. Medical Journal

of Islamic World Academy of Sciences, 109(1567), 1-6.

 

Navarro-González, J. F., Muros, M., Mora-Fernández, C., Herrera, H., Meneses, B., &

García, J. (2011). Pentoxifylline for renoprotection in diabetic nephropathy: the

PREDIAN study. Rationale and basal results. Journal of Diabetes and Its

Complications, 25(5), 314-319.

 

Ng, D. P., Nurbaya, S., Sandra, H. J., & Krolewski, A. S. (2008). An IL-6 haplotype on

human chromosome 7p21 confers risk for impaired renal function in type 2

diabetic patients. Kidney International, 74(4), 521-527.

 

Ng, M. C., Shriner, D., Chen, B. H., Li, J., Chen, W. M., Guo, X., & Comeau, M. E.

(2014). Meta-analysis of genome-wide association studies in African Americans

provides insights into the genetic architecture of type 2 diabetes. PLoS

Genetics, 10(8), e1004517.

 

Newton, C. R., Graham, A., Heptinstall, L. E., Powell, S. J., Summers, C., Kalsheker,

N., ... & Markham, A. F. (1989). Analysis of any point mutation in DNA. The

amplification refractory mutation system (ARMS). Nucleic Acids

Research, 17(7), 2503-2516.

 

Nuhiar, R. S., Salman, A. N., & AL-Rekaby, H. R. (2018). The some cytokines Levels

(TGFβ1, IL-4, IL-6, and IL-17) in sera Patients with Diabetes Mellitus Type1,

Type 2 in Nassiriya city. Journal of Thi-qar Science, 6(4), 42-48.

 

Ogurtsova, K., da Rocha Fernandes, J. D., Huang, Y., Linnenkamp, U., Guariguata, L.,

Cho, N. H., ... & Makaroff, L. E. (2017). IDF Diabetes Atlas: Global estimates for

the prevalence of diabetes for 2015 and 2040. Diabetes Research and Clinical

Practice, 128, 40-50.

 

Olokoba, A. B., Obateru, O. A., & Olokoba, L. B. (2012). Type 2 diabetes mellitus: a

review of current trends. Oman Medical Journal, 27(4), 269.

 

Ozougwu, J. C., Obimba, K. C., Belonwu, C. D., & Unakalamba, C. B. (2013). The

pathogenesis and pathophysiology of type 1 and type 2 diabetes mellitus. Journal

of Physiology and Pathophysiology, 4(4), 46-57.

 

Okayama, H., Curiel, D. T., Brantly, M. L., Holmes, M. D., & Crystal, R. G. (1989).

Rapid, nonradioactive detection of mutations in the human genome by allelespecific

amplification. The Journal of Laboratory and Clinical Medicine, 114(2),

105-113.

 

Oberbach, A., Lehmann, S., Kirsch, K., Krist, J., Sonnabend, M., Linke, A., & Kovacs,

P. (2008). Long-term exercise training decreases interleukin-6 (IL-6) serum levels

in subjects with impaired glucose tolerance: effect of the− 174G/C variant in IL-6

gene. European Journal of Endocrinology, 159(2), 129-136.

 

Oguntibeju, O. O. (2019). Type 2 diabetes mellitus, oxidative stress and inflammation:

examining the links. International Journal of Physiology, Pathophysiology and

Pharmacology, 11(3), 45.

 

Pan, A., Wang, Y., Talaei, M., Hu, F. B., & Wu, T. (2015). Relation of active, passive,

and quitting smoking with incident type 2 diabetes: a systematic review and metaanalysis.

The Lancet Diabetes and Endocrinology, 3(12), 958-967.

 

Papaetis, Georgios S, Panagiotis Papakyriakou, and Themistoklis N Panagiotou.

(2015). Central obesity , type 2 diabetes and insulin : exploring a pathway full of

thorns. Archives of Medical Science: AMS, 11(3), 463.

 

Patel, T. P., Rawal, K., Bagchi, A. K., Akolkar, G., Bernardes, N., da Silva Dias, D., &

Singal, P. K. (2016). Insulin resistance: an additional risk factor in the

pathogenesis of cardiovascular disease in type 2 diabetes. Heart Failure

Reviews, 21(1), 11-23.

 

Pesu, M., Takaluoma, K., Aittomäki, S., Lagerstedt, A., Saksela, K., Kovanen, P. E., &

Silvennoinen, O. (2000). Interleukin-4-induced transcriptional activation by stat6

involves multiple serine/threonine kinase pathways and serine phosphorylation of

stat6. Blood, 95(2), 494-502.

 

Peters, S. A., Huxley, R. R., & Woodward, M. (2016). Sex differences in body

anthropometry and composition in individuals with and without diabetes in the

UK Biobank. British Medical Journal BMJ Open, 6(1), e010007.

 

Prasad, R., & Groop, L. (2015). Genetics of type 2 diabetes—pitfalls and

possibilities. Genes, 6(1), 87-123.

 

Popko, K., Gorska, E., & Demkow, U. (2010). Influence of interleukin-6 and G174C

polymorphism in IL-6 gene on obesity and energy balance. European Journal of

Medical Research, 15(2), 123.

 

Punthakee, Z., Goldenberg, R., & Katz, P. (2018). Definition, classification and

diagnosis of diabetes, prediabetes and metabolic syndrome. Canadian Journal of

Diabetes, 42, S10-S15.

 

Panagi, L., Poole, L., Hackett, R. A., & Steptoe, A. (2019). Sex differences in

interleukin-6 stress responses in people with Type 2 diabetes. Psychophysiology,

56(6), e13334.

 

Pradhan, A. D., Manson, J. E., Rifai, N., Buring, J. E., & Ridker, P. M. (2001). Creactive

protein, interleukin 6, and risk of developing type 2 diabetes mellitus.

Jama, 286(3), 327-334.

 

Perry, J. R., Voight, B. F., Yengo, L., Amin, N., Dupuis, J., Ganser, M., &

Steinthorsdottir, V. (2012). Stratifying type 2 diabetes cases by BMI identifies

genetic risk variants in LAMA1 and enrichment for risk variants in lean compared

to obese cases. PLoS Genetics, 8(5), e1002741.

 

Palmer, N. D., McDonough, C. W., Hicks, P. J., Roh, B. H., Wing, M. R., An, S. S., &

Talbert, M. E. (2012). A genome-wide association search for type 2 diabetes genes

in African Americans. PloS one, 7(1), e29202.

 

Prokopenko, I., Langenberg, C., Florez, J. C., Saxena, R., Soranzo, N., Thorleifsson,

G., & Potter, S. C. (2009). Variants in MTNR1B influence fasting glucose

levels. Nature Genetics, 41(1), 77-81.

 

Qi, L., van Dam, R. M., Meigs, J. B., Manson, J. E., Hunter, D., & Hu, F. B. (2006).

Genetic variation in IL6 gene and type 2 diabetes: tagging-SNP haplotype analysis

in large-scale case–control study and meta-analysis. Human Molecular

Genetics, 15(11), 1914-1920.

 

Qu, D., Liu, J., Lau, C. W., & Huang, Y. (2014). IL-6 in Diabetes and Cardiovascular

Complications. British Journal of Pharmacology, 171: 3595–3603.

 

Qi, L., Cornelis, M. C., Kraft, P., Stanya, K. J., Linda Kao, W. H., Pankow, J. S., &

Sun, Q. (2010). Genetic variants at 2q24 are associated with susceptibility to type

2 diabetes. Human Molecular Genetics, 19(13), 2706-2715.

 

Radha, Venkatesan, Sekar Kanthimathi, Ranjit Mohan Anjana, and Viswanathan

Mohan. (2016). Genetics of Gestational Diabetes Mellitus. JPMA. The Journal of

the Pakistan Medical Association 66(9): S11–14.

 

Raghavan, S., Pachucki, M. C., Chang, Y., Porneala, B., Fox, C. S., Dupuis, J., &

Meigs, J. B. (2016). Incident type 2 diabetes risk is influenced by obesity and

diabetes in social contacts: a social network analysis. Journal of General Internal

Medicine, 31(10), 1127-1133.

 

Russell, J. W., & Zilliox, L. A. (2014). Diabetic neuropathies. Continuum: Lifelong

Learning in Neurology, 20(5 Peripheral Nervous System Disorders), 1226.

 

Román-Pintos, L. M., Villegas-Rivera, G., Rodríguez-Carrizalez, A. D., Miranda-Díaz,

A. G., & Cardona-Muñoz, E. G. (2016). Diabetic polyneuropathy in type 2

diabetes mellitus: inflammation, oxidative stress, and mitochondrial

function. Journal of Diabetes Research, 2016.

 

Ranasinghe, P., Cooray, D. N., Jayawardena, R., & Katulanda, P. (2015). The influence

of family history of hypertension on disease prevalence and associated metabolic

risk factors among Sri Lankan adults. BMC Public Health, 15(1), 576.

 

Rao, P., Wang, H., Fang, H., Gao, Q., Zhang, J., Song, M., & Wang, W. (2016).

Association between IGF2BP2 polymorphisms and type 2 diabetes mellitus: a

case–control study and meta-analysis. International Journal of Environmental

Research and Public Health, 13(6), 574.

 

Rehman, K., & Akash, M. S. H. (2016). Mechanisms of inflammatory responses and

development of insulin resistance: how are they interlinked? Journal of Biomedical Science, 23(1), 87.

 

Riddy, D. M., Delerive, P., Summers, R. J., Sexton, P. M., & Langmead, C. J. (2018).

G protein–coupled receptors targeting insulin resistance, obesity, and type 2

diabetes mellitus. Pharmacological Reviews, 70(1), 39-67.

 

Rodrigues, K. F., Pietrani, N. T., Bosco, A. A., Campos, F. M. F., Sandrim, V. C., &

Gomes, K. B. (2017). IL-6, TNF-α, and IL-10 levels/polymorphisms and their

association with type 2 diabetes mellitus and obesity in Brazilian

individuals. Archives of Endocrinology and Metabolism, 61(5), 438-446.

 

Rudofsky Jr, G., Schlotterer, A., Reismann, P., Engel, J., Grafe, I. A., Tafel, J., &

Hamann, A. (2009). The− 174G> C IL-6 gene promoter polymorphism and

diabetic microvascular complications. Hormone and Metabolic Research, 41(04),

308-313.

 

Rosengren, A. H., Jokubka, R., Tojjar, D., Granhall, C., Hansson, O., Li, D. Q., &

Groop, L. (2010). Overexpression of alpha2A-adrenergic receptors contributes to

type 2 diabetes. Science, 327(5962), 217-220.

 

Rung, J., Cauchi, S., Albrechtsen, A., Shen, L., Rocheleau, G., Cavalcanti-Proença, C.,

& Charpentier, G. (2009). Genetic variant near IRS1 is associated with type 2

diabetes, insulin resistance and hyperinsulinemia. Nature Genetics, 41(10), 1110.

 

Sulaiman, M. K. (2019). Diabetic nephropathy: recent advances in pathophysiology and

challenges in dietary management. Diabetology & Metabolic Syndrome, 11(1), 7.

 

Salman, Ali Naeem. 2018. The Some Cytokines Levels (TGFβ1, IL-4 , IL-6, and IL-

17) in Sera Patients with Diabetes Mellitus Type1,Type 2 in Nassiriya City

1Rasha. Rasha Salih Nuhiar 6(4).

 

Sarvas, J. L., Khaper, N., & Lees, S. J. (2013). The IL-6 paradox: context dependent

interplay of SOCS3 and AMPK. Journal of Diabetes and Metabolism, 13(15).

 

Saxena, M., Srivastava, N., & Banerjee, M. (2013). Association of IL-6, TNF-α and IL-

10 gene polymorphisms with type 2 diabetes mellitus. Molecular Biology

Reports, 40(11), 6271-6279.

 

Saxena, M., & Modi, D. R. (2014). Inflammation and diabetes. Interdisciplinary

Journal of Microinflammation, 1(110), 2.

 

Saxena, M., Agrawal, C. G., Srivastava, N., & Banerjee, M. (2014). Interleukin-6 (IL-

6)-597 A/G (rs1800797) &-174 G/C (rs1800795) gene polymorphisms in type 2

diabetes. The Indian Journal of Medical Research, 140(1), 60.

 

Sarkar, G., Cassady, J., Bottema, C. D., & Sommer, S. S. (1990). Characterization of

polymerase chain reaction amplification of specific alleles. Analytical

Biochemistry, 186(1), 64-68.

 

Shiau, M. Y., Lu, H. F., Chang, Y. H., Chiu, Y. C., & Shih, Y. L. (2015).

Characterization of proteins regulated by interleukin-4 in 3T3-L1

adipocytes. SpringerPlus, 4(1), 242.

 

Shih, Y. L., Ho, K. T., Tsao, C. H., Chang, Y. H., Shiau, M. Y., Huang, C. N., & Yang,

S. C. (2013). Role of cyotkines in metabolism and type 2 diabetes

mellitus. International Journal of Biomedical Laboratory Science, 2(1), 1-6.

 

Sindhughosa, D. A., & Pranamartha, A. G. M. K. (2017). The involvement of

proinflammatory cytokines in diabetic nephropathy: Focus on interleukin 1 (IL-

1), interleukin 6 (IL-6), and tumor necrosis factor-alpha (TNF-α) signaling

mechanism. Bali Medical Journal, 6, 299.

 

Sorkin, D. H., Mavandadi, S., Rook, K. S., Biegler, K. A., Kilgore, D., Dow, E., & Ngo-

Metzger, Q. (2014). Dyadic collaboration in shared health behavior change: the

effects of a randomized trial to test a lifestyle intervention for high-risk

Latinas. Health Psychology, 33(6), 566.

 

Stancáková, A., & Laakso, M. (2016). Genetics of type 2 diabetes. In Novelties in

Diabetes 31, 203-220.

 

Steffen, B. T., Steffen, L. M., Zhou, X., Ouyang, P., Weir, N. L., & Tsai, M. Y. (2015).

n-3 Fatty acids attenuate the risk of diabetes associated with elevated serum

nonesterified fatty acids: the multi-ethnic study of atherosclerosis. Diabetes

Care, 38(4), 575-580.

 

Stephens, J. W., Hurel, S. J., Cooper, J. A., Acharya, J., Miller, G. J., & Humphries, S.

E. (2004). A common functional variant in the interleukin-6 gene is associated

with increased body mass index in subjects with type 2 diabetes

mellitus. Molecular Genetics and Metabolism, 82(2), 180-186.

 

Steppan, C. M., Bailey, S. T., Bhat, S., Brown, E. J., Banerjee, R. R., Wright, C. M., &

Lazar, M. A. (2001). The hormone resistin links obesity to

diabetes. Nature, 409(6818), 307.

 

Strawbridge, R. J., Dupuis, J., Prokopenko, I., Barker, A., Ahlqvist, E., Rybin, D., &

Nica, A. (2011). Genome-wide association identifies nine common variants

associated with fasting proinsulin levels and provides new insights into the

pathophysiology of type 2 diabetes. Diabetes, 60(10), 2624-2634.

 

Scott, R. A., Lagou, V., Welch, R. P., Wheeler, E., Montasser, M. E., Mägi, R., &

Rasmussen-Torvik, L. J. (2012). Large-scale association analyses identify new

loci influencing glycemic traits and provide insight into the underlying biological

pathways. Nature genetics, 44(9), 991-1005.

 

Saxena, R., Hivert, M. F., Langenberg, C., Tanaka, T., Pankow, J. S., Vollenweider, P.,

& Kao, W. L. (2010). Genetic variation in GIPR influences the glucose and insulin

responses to an oral glucose challenge. Nature Genetics, 42(2), 142-148.

 

Saxena, R., Elbers, C. C., Guo, Y., Peter, I., Gaunt, T. R., Mega, J. L., & Johnson, T.

(2012). Large-scale gene-centric meta-analysis across 39 studies identifies type 2

diabetes loci. The American Journal of Human Genetics, 90(3), 410-425.

 

Saxena, R., Saleheen, D., Been, L. F., Garavito, M. L., Braun, T., Bjonnes, A., & Sim,

X. (2013). Genome-wide association study identifies a novel locus contributing to

type 2 diabetes susceptibility in Sikhs of Punjabi origin from

India. Diabetes, 62(5), 1746-1755.

 

Saxena, R., Voight, B. F., Lyssenko, V., Burtt, N. P., de Bakker, P. I., Chen, H., &

Hughes, T. E. (2007). Diabetes Genetics Initiative of Broad Institute of Harvard

and MIT, Lund University, and Novartis Institutes of BioMedical Research.

Genome-wide association analysis identifies loci for type 2 diabetes and

triglyceride levels. Science, 316(5829), 1331-1336.

 

Sladek, R., Rocheleau, G., Rung, J., Dina, C., Shen, L., Serre, D., & Balkau, B. (2007).

A genome-wide association study identifies novel risk loci for type 2

diabetes. Nature, 445(7130), 881-885.

 

Shu, X. O., Long, J., Cai, Q., Qi, L., Xiang, Y. B., Cho, Y. S., & Go, M. J. (2010).

Identification of new genetic risk variants for type 2 diabetes. PLoS Genetics, 6(9),

e1001127.

 

Sandhu, M. S., Weedon, M. N., Fawcett, K. A., Wasson, J., Debenham, S. L., Daly, A.,

& Blech, I. (2007). Common variants in WFS1 confer risk of type 2

diabetes. Nature Genetics, 39(8), 951-953.

 

Sambrook, J., Fritsch, E. F., and Maniatis, T. (1989) Molecular Cloning: A Laboratory

Manual, 2nd Ed., Cold Spring Harbor Laboratory, Cold Spring, NY

 

Sim, X., Ong, R. T. H., Suo, C., Tay, W. T., Liu, J., Ng, D. P. K., & Teo, Y. Y. (2011).

Transferability of type 2 diabetes implicated loci in multi-ethnic cohorts from

Southeast Asia. PLoS Genetics, 7(4), e1001363.

 

Steinthorsdottir, V., Thorleifsson, G., Reynisdottir, I., Benediktsson, R., Jonsdottir, T.,

Walters, G. B., & Baker, A. (2007). A variant in CDKAL1 influences insulin

response and risk of type 2 diabetes. Nature Genetics, 39(6), 770-775.

 

Talaei, A., Mohamadi, M., & Adgi, Z. (2013). The effect of vitamin D on insulin

resistance in patients with type 2 diabetes. Diabetology and Metabolic

Syndrome, 5(1), 8.

 

Tallapragada, D. S. P., Bhaskar, S., & CHANDAK, G. R. (2015). New insights from

monogenic diabetes for “common” type 2 diabetes. Frontiers in Genetics, 6, 251.

 

Tariq, Rehan, Khalid Idrees Khan, Rizwan Ali Masood, and Zafeer Naeem Wain. 2016.

Natural Remedies for Diabetes Mellitus. International Current Pharmaceutical

Journal Review 5(11): 97–102.

 

Tolman, K. G., Fonseca, V., Dalpiaz, A., & Tan, M. H. (2007). Spectrum of liver

disease in type 2 diabetes and management of patients with diabetes and liver

disease. Diabetes Care, 30(3), 734-743.

 

Tsao, C. H., Shiau, M. Y., Chuang, P. H., Chang, Y. H., & Hwang, J. (2014).

Interleukin-4 regulates lipid metabolism by inhibiting adipogenesis and promoting

lipolysis. Journal of Lipid Research, 55(3), 385-397.

 

Turner, M. D., Nedjai, B., Hurst, T., & Pennington, D. J. (2014). Cytokines and

chemokines: at the crossroads of cell signalling and inflammatory

disease. Biochimica et Biophysica Acta (BBA)-Molecular Cell

Research, 1843(11), 2563-2582.

 

Testa, R., Olivieri, F., Bonfigli, A. R., Sirolla, C., Boemi, M., Marchegiani, F., &

Paolisso, G. (2006). Interleukin-6–174 G> C polymorphism affects the association

between IL-6 plasma levels and insulin resistance in type 2 diabetic

patients. Diabetes Research and Clinical Practice, 71(3), 299-305.

 

Tsai, F. J., Yang, C. F., Chen, C. C., Chuang, L. M., Lu, C. H., Chang, C. T., & Chang,

C. C. (2010). A genome-wide association study identifies susceptibility variants

for type 2 diabetes in Han Chinese. PLoS Genet, 6(2), e1000847.

 

Thorleifsson, G., Walters, G. B., Gudbjartsson, D. F., Steinthorsdottir, V., Sulem, P.,

Helgadottir, A., & Jonsdottir, T. (2009). Genome-wide association yields new

sequence variants at seven loci that associate with measures of obesity. Nature

genetics, 41(1), 18-24.

 

Tabassum, R., Chauhan, G., Dwivedi, O. P., Mahajan, A., Jaiswal, A., Kaur, I., &

Chidambaram, M. (2013). Genome-wide association study for type 2 diabetes in

Indians identifies a new susceptibility locus at 2q21. Diabetes, 62(3), 977-986.

 

Underwood, P. C., Chamarthi, B., Williams, J. S., Sun, B., Vaidya, A., Raby, B. A., &

Williams, G. H. (2012). Replication and meta-analysis of the gene-environment

interaction between body mass index and the interleukin-6 promoter

polymorphism with higher insulin resistance. Metabolism, 61(5), 667-671.

 

Unnikrishnan, R., Pradeepa, R., Joshi, S. R., & Mohan, V. (2017). Type 2 diabetes:

demystifying the global epidemic. Diabetes, 66(6), 1432-1442.

 

Vana, D. R., Adapa, D., Prasad, V. S. S., Choudhury, A., & Ahuja, G. (2019). Diabetes

mellitus types: key genetic determinants and risk assessment. Genetics and

Molecular Research, 18(2).

 

Vornanen, M., Konttinen, H., Kääriäinen, H., Männistö, S., Salomaa, V., Perola, M., &

Haukkala, A. (2016). Family history and perceived risk of diabetes, cardiovascular

disease, cancer, and depression. Preventive Medicine, 90, 177-183.

 

Votsi, C., Toufexis, C., Michailidou, K., Antoniades, A., Skordis, N., Karaolis, M., &

Christodoulou, K. (2017). Type 2 diabetes susceptibility in the Greek-Cypriot

population: replication of associations with TCF7L2, FTO, HHEX, SLC30A8 and

IGF2BP2 polymorphisms. Genes, 8(1), 16.

 

Vozarova, B., Fernández-Real, J. M., Knowler, W. C., Gallart, L., Hanson, R. L.,

Gruber, J. D., & Wolford, J. K. (2003). The interleukin-6 (− 174) G/C promoter

polymorphism is associated with type-2 diabetes mellitus in Native Americans and

Caucasians. Human Genetics, 112(4), 409-413.

 

Vozarova, B., Weyer, C., Hanson, K., Tataranni, P. A., Bogardus, C., & Pratley, R. E.

(2001). Circulating interleukin-6 in relation to adiposity, insulin action, and insulin

secretion. Obesity Research, 9(7), 414-417.

 

Vidhate, D. A., Thomas, J., & Gupte, A. M. (2013). Association of IL-6 with diabetes

mellitus in Indian population from Navi Mumbai. International Journal of Recent

Trends in Science and Technology, 8(2), 100-102.

 

Vieira Ribeiro, F., de Mendonça, A. C., Santos, V. R., Bastos, M. F., Figueiredo, L. C.,

& Duarte, P. M. (2011). Cytokines and bone-related factors in systemically healthy

patients with chronic periodontitis and patients with type 2 diabetes and chronic

periodontitis. Journal of Periodontology, 82(8), 1187-1196.

 

Voight, B. F., Scott, L. J., Steinthorsdottir, V., Morris, A. P., Dina, C., Welch, R. P., &

McCulloch, L. J. (2010). Twelve type 2 diabetes susceptibility loci identified

through large-scale association analysis. Nature Genetics, 42(7), 579.

 

Weisberg, S. P., McCann, D., Desai, M., Rosenbaum, M., Leibel, R. L., & Ferrante, A.

W. (2003). Obesity is associated with macrophage accumulation in adipose

tissue. The Journal of Clinical Investigation, 112(12), 1796-1808.

 

Wang, G., Zhang, Q., Xu, N., Xu, K., Wang, J., He, W., & Yang, T. (2014).

Associations between two polymorphisms (FokI and BsmI) of vitamin D receptor

gene and type 1 diabetes mellitus in Asian population: a meta-analysis. PLoS

One, 9(3), e89325.

 

Wedrychowicz, A., Dziatkowiak, H., & Sztefko, K. (2004). Interleukin-6 (IL-6) and

IGF-IGFBP system in children and adolescents with type 1 diabetes

mellitus. Experimental and Clinical Endocrinology and Diabetes, 112(08), 435-

439.

 

Wei, H., Feng, G., Pei, W., Gang, W., & Yuelin, Z. (2017). Association between

interleukin-4 genetic polymorphisms and the risk of cerebral infarction in a

population of China. Biomedical Research, 28(21), 9198-9203.

 

Wu, Y. L., Ding, Y. P., Gao, J., Tanaka, Y., & Zhang, W. (2013). Risk factors and

primary prevention trials for type 1 diabetes. International Journal of Biological

Sciences, 9(7), 666.

 

Wu, Y., Ding, Y., Tanaka, Y., & Zhang, W. (2014). Risk factors contributing to type 2

diabetes and recent advances in the treatment and prevention. International

Journal of Medical Sciences, 11(11), 1185.

 

Wu, D. Y., Ugozzoli, L., Pal, B. K., & Wallace, R. B. (1989). Allele-specific enzymatic

amplification of beta-globin genomic DNA for diagnosis of sickle cell

anemia. Proceedings of the National Academy of Sciences, 86(8), 2757-2760.

 

Wu, Y., Jing, R., Dong, Y., Kuang, Q., Li, Y., Huang, Z., & Li, M. (2017). Functional

annotation of sixty-five type-2 diabetes risk SNPs and its application in risk

prediction. Scientific Reports, 7, 43709.

 

Weedon, M. N., Schwarz, P. E., Horikawa, Y., Iwasaki, N., Illig, T., Holle, R., & Evans,

J. (2003). Meta-analysis and a large association study confirm a role for calpain-

10 variation in type 2 diabetes susceptibility. The American Journal of Human

Genetics, 73(5), 1208-1212.

 

Xia, C., Rao, X., & Zhong, J. (2017). Role of T lymphocytes in type 2 diabetes and

diabetes-associated inflammation. Journal of diabetes research, 2017.

 

Xiao, L. M., Yan, Y. X., Xie, C. J., Fan, W. H., Xuan, D. Y., Wang, C. X., & Zhang, J.

C. (2009). Association among interleukin-6 gene polymorphism, diabetes and

periodontitis in a Chinese population. Oral Diseases, 15(8), 547-553.

 

Yang, Q. H., Zhang, Y., Zhang, X. M., & Li, X. R. (2019). Prevalence of diabetic

retinopathy, proliferative diabetic retinopathy and non-proliferative diabetic

retinopathy in Asian T2DM patients: a systematic review and Metaanalysis.

International Journal of Ophthalmology, 12(2), 302.

 

Yao, L., Tak, Y. G., Berman, B. P., & Farnham, P. J. (2014). Functional annotation of

colon cancer risk SNPs. Nature Communications, 5, 5114.

 

Yamauchi, T., Hara, K., Maeda, S., Yasuda, K., Takahashi, A., Horikoshi, M., & Ng,

D. P. (2010). A genome-wide association study in the Japanese population

identifies susceptibility loci for type 2 diabetes at UBE2E2 and C2CD4AC2CD4B.

Nature Genetics, 42(10), 864-868.

 

Zaccardi, F., O'Donovan, G., Webb, D. R., Yates, T., Kurl, S., Khunti, K., &

Laukkanen, J. A. (2015). Cardiorespiratory fitness and risk of type 2 diabetes

mellitus: A 23-year cohort study and a meta-analysis of prospective

studies. Atherosclerosis, 243(1), 131-137.

 

Zaharieva, E., Kamenov, Z., Velikova, T., Tsakova, A., El-Darawish, Y., & Okamura,

H. (2018). Interleukin-18 serum level is elevated in type 2 diabetes and latent

autoimmune diabetes. Endocrine Connections, 7(1), 179-185.

 

Zamorano, J., Rivas, M. D., & Perez, G. M. (2003). Interleukin-4: A multifunctional

cytokine. Inmunologia, 22, 215-24.

 

Zhang, C., Bao, W., Rong, Y., Yang, H., Bowers, K., Yeung, E., & Kiely, M. (2013).

Genetic variants and the risk of gestational diabetes mellitus: a systematic

review. Human Reproduction Update, 19(4), 376-390.

 

Zhang, X., Ma, L., Peng, F., Wu, Y., Chen, Y., Yu, L., & Zhang, C. (2011). The

endothelial dysfunction in patients with type 2 diabetes mellitus is associated with

IL-6 gene promoter polymorphism in Chinese population. Endocrine, 40(1), 124.